Lectures and associated resources available August 25, 2021
David Devos, Anna Sauerbier, and Per Odin
To be announced.
This course will provide knowledge about the neuropharmacological basis of treatment of advanced Parkinson´s disease (APD). It will also give a theoretical and practical education in the indication and the management of pump-based treatments for APD (including Levodopa-carbidopa intestinal gel, Levodopa-carbidopa entacapone intestinal gel and apomorphine). The course includes lectures on neuropharmacology, experimental basis of continuous dopaminergic stimulation (past, current and future treatments), history, patient selection, effects, side effects and practical management, as well as, interactive workshops on patient selection and choice of advanced therapy. An emphasis will also be case-based presentations.
Lectures will be streamed live to participants on the days of the course. In addition to the didactic lectures, faculty will lead interactive workshops concerning patient selection and choice of advanced therapies. Faculty will also presenting interactive case based presentations.
This course is intended for Basic Science Researchers, Translational Researchers, Clinical Researchers, Clinical Nurse Specialists, Physio / Physical Therapists, and Occupational Therapists
Describe the neuropharmacological background for treatment of advanced Parkinson´s disease, including the relevance of continuous dopaminergic stimulation-based treatment
Define the criteria and process for selecting the ideal patients for advanced Parkinson’s disease therapy through therapy comparison for a balanced outlook
Compare the effects of pump treatment on motor and non-motor symptoms, quality of life, and the real-life based safety aspects of these therapies
Demonstrate practical handling of pump-based therapies
Plan a unit for pump-based therapies – what is needed?